immunogenic
IPA: ˈɪmjunoʊdʒˈɛnɪk
adjective
- (immunology) that produces a reaction from the immune system; antigenic.
Advertisement
Examples of "immunogenic" in Sentences
- Existing medical superglues are highly immunogenic.
- Generally, the larger the immunogenic protein the better.
- Anthracyclins produce a beneficial immunogenic environment.
- Reactogenicity and immunogenicity of a new live attenuated ...
- For instance a hapten is an antigenic substance but not immunogenic.
- Reactogenicity and immunogenicity of a live attenuated tetravalent ...
- Number of immunogenic proteins or sugars (polysaccharides) contained in vaccines over the past 100 years
- Biotechnological advances resulted in a new antivenin that proports to be less immunogenic than the standard antivenin.
- It is now understood, however, that some chemotherapeutic agents referred to as "immunogenic" may enhance the antitumor effects of immunotherapy by acting directly on the tumor and host environment.
- Scientists have believed that Buchnera bacteria live peacefully within aphids, because they have evolved to be non-immunogenic, meaning they have lost the ability to trigger an immune response in any host.
- This so-called immunogenic carrier molecule comes solely from the rare keyhole limpet, and Stellar has technology for the maintenance of the animal, the non-lethal extraction of the critical molecule and a profitable refinement process of KLH.
- So we will know after these clinical trials whether one or two doses are needed and this will also give confirmation that the formulation that the manufacturers are using are indeed immunogenic and are likely to induce protection again the pandemic virus.
- These adverse events often included anaphylactoid reactions (23 percent) and serum sickness (50 percent) .1 Although most adverse events did not result in mortality when treated with appropriate medication, such complications are problematic and fueled the development of a less immunogenic antivenin.
- "Recent findings suggest that, due to its anti-tumor immunomodulatory activities, NOV-002 may be particularly well-suited for combination with certain 'immunogenic' chemotherapy agents including cyclophosphamide and doxorubicin which are commonly used to treat breast cancer and are part of the treatment regimen used in this trial."